Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000310
Status:
TERMINATED
Last Update Posted:
2017-01-16
First Post:
1999-09-20
Brief Title:
SerotoninDopamine Antagonism of Cocaine Effect 2 - 2
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
SerotoninDopamine Antagonism of Cocaine Effect
Status:
TERMINATED
Status Verified Date:
1996-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate use of risperidone with cocaine abusers Study measures incorporate an appropriate integration of behavioral and neurobiological indices
Detailed Description:
Risperidone in low doses is compared with placebo in a 6-week randomized trial Subjects also receive supportive counseling Outcome measure include rating of behavior mood drug abuse global function and urine toxicology
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-09330-2 | None | None | None |